FIELD: pharmacology.
SUBSTANCE: invention relates to compounds of the formula or to their pharmaceutically acceptable salts, wherein X, R1, R2, R3 and A are as defined in the claims. The compounds of formula (I) are modulators of leucine-repeating kinase 2 (LRRK2) modulators.
EFFECT: application fortreatment of diseases associated with the LRRK2 receptor, such as Parkinson's disease.
20 cl, 2 tbl, 53 ex
Authors
Dates
2017-12-08—Published
2013-04-30—Filed